Confessions of a Corporate Insurgent with Gib Bulloch

OutsideVoices with Mark Bidwell

In this episode, writer, speaker, and intrapreneur, Gib Bulloch, joins us to discuss his book, The Intrapreneur: Confessions of a Corporate Insurgent. He spent 20 years at Accenture where he started Accenture Development Partnerships (ADP), a buinsess unit set up to leverage that business’s expertise and experience in service of global development organizations.Gib now works as a consultant specializing in intrapreneurship, social enterprise, and cross-sectoral partnerships. He is also a noted public speaker and has contributed to The Huffington Post, Businessweek, and The Stanford Social Innovation Review.

What Is Covered

• Why CEOs and leaders need to make changes in organisational processes and to cultural norms to reflect the changing needs of the workforce of tomorrow
• How best practices from the world’s most admired companies can be used to deliver impact via the work of global development organizations
• Why if people “want to think out of the box" they need to get out of the box to apply their skills; a different context as a way of seeing things they would not otherwise see in their normal daily routines

Key Takeaways and Learnings

• How organisational cultures, norms, and middle management (the “corporate immune system”) conspire invisibly to stop innovation in its tracks
• The power of bottom-up change; Gib’s call to action for millennials to push for change within their organizations both individually and collectively
• The possibilities of “not for loss” business models that are cost neutral to shareholders and have measurable business benefits

Links and Resources Mentioned in this Episode

• Get in touch with Gib Bulloch via email, LinkedIn or Twitter
• Gib's website
• The Intrapreneur: The Confessions of a Corporate Insurgent, a book by Gib Bulloch
• World Economic Forum at Davos speech
• Accenture, website
• Other mentions: British Petroleum, Hay Group, Voluntary Service Organization, The Gates foundation, GSK